Eris Lifesciences Ltd.

Financial

	Eris Lifesciences	Caplin Point Lab	Astrazeneca Pharma I
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	10.7 %	n/a	18.6 %
R&D as a % of Total Sales	0.0	4.07 %	0.0
Financials
5 yr Average ROE	19.85 %	20.61 %	18.37 %
5yr average Equity Multiplier	1.5	1.17	1.94
5yr Average Asset Turnover Ratio	0.58	0.72	0.94
5yr Avg Net Profit Margin	25.85 %	24.8 %	10.03 %
Price to Book	6.34	6.59	25.44
P/E	50.45	33.95	211.0
5yr Avg Cash Conversion Cycle	-99.43 Days	79.85 Days	-36.14 Days
Inventory Days	26.22 Days	64.55 Days	64.11 Days
Days Receivable	61.69 Days	100.92 Days	36.53 Days
Days Payable	164.23 Days	74.04 Days	208.62 Days
5yr Average Interest Coverage Ratio	94.87	579.71	140.96
5yr Avg ROCE	21.14 %	25.27 %	23.99 %
5yr Avg Operating Profit Margin	34.25 %	30.87 %	14.51 %
5 yr average Debt to Equity	0.29	0.01	0.0
5yr CAGR Net Profit	5.74 %	16.28 %	17.47 %
5yr Average Return on Assets	15.49 %	17.7 %	9.52 %
Shareholdings
Promoter Holding	54.87 %	70.56 %	75.0 %
Share Pledged by Promoters	18.51 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	2.19 %	1.53 %	0.0
Change in Mutual Fund Holding (3 Yrs)	7.46 %	0.48 %	4.12 %

Business

	Eris Lifesciences	Caplin Point Lab	Astrazeneca Pharma I
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Branded Generic 0 Generic 0 Clinical trials 0 Pharmaceutical products 0	Product Wise Break-Up Pharmaceutical products 0 Pharmaceutical 0 Branded Generics 25.0 Formulations 75.0 Clinical trials 0	Product Wise Break-Up Pharmaceutical 93.06 Pharmaceutical 0 Branded Generic 0 Generic 0 Clinical Trial 6.94
Entity Wise Breakup	Entity Wise Breakup Eris Standalone 95.21 Aprica (BGx) 4.68 Eris M J (Insulin) 0.1 EHPL (TGx) 0 Oaknet (BGx) 0 Others 0.01	-	-
EBITDA - Entity Wise	EBITDA - Entity Wise Eris M J (Insulin) 0 EHPL (TGx) 0 Aprica (BGx) 0 Oaknet (BGx) 0 Eris (Standalone) 0 Others 100	-	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 32.0 Cardiac Science 16.0 Vitamins / Minerals / Nutrients 14.0 Dermatology 11.0 Central Nervous System (CNS) 5.0 Oncology 4.0 Pain/Analhesics 0 Gastro Intestinal 0 Gynaecology 0 Others 18.0	-	-
Location Wise Break-Up	Location Wise Break-Up South India 35.0 West India 30.0 North India 16.0 East India 15.0 USA 0 India 0 Africa 0 LATAM 0 Rest of the World 0 Others 4.0	Location Wise Break-Up West India 0 North India 0 Africa 2.0 Latin America 80.0 India 0 East India 0 Rest of the World 0 South India 0 USA 18.0	Location Wise Break-Up West India 0 North India 0 Africa 0 LATAM 0 India 93.61 East India 0 Rest of the World 6.39 South India 0 USA 0
Acute vs Chronic	Acute vs Chronic Chronic + Sub Chronic Therapies 86.0 Acute 14.0	-	-

Eris Lifesciences Ltd.

SIGN UP FOR FREE